Skip to content
Delayed ~15 min

PRCT PROCEPT BIOROBOTICS

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: not announced yet

What 18 analyst firms say about PROCEPT BIOROBOTICS: their latest ratings, price targets and how far the stock is from them. How it works

20.62 USD+0.35 (+1.73%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+7.9%to the avg target 22.25 USD+1.63 USD
Buy 6 · Hold 10 · Sell 1

17 rated views · 20 analyst/firm records · 18 firms

Latest report12 Oct 2026avg report date 3 Aug
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8022
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8041

Recent analyst activity · last 90 days

Our tracked history has 9 reports on PRCT from 7 analyst firms in the last 90 days (19 firms in the past year).

Comparing each firm's latest target with its previous one: 3 raised their price target and 1 left it unchanged.

No firm's latest available rating differs from its previous one.

Latest observed target change: SVB Leerink raised its target from $20.00 (set 12 Oct 2026) to $22.00 on 5 Nov 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
BairdDavid RescottHold14 Jul 202620.00 USD
Bank of America SecuritiesCraig BijouSell26 Feb 202620.00 USD
BarclaysChristopher PasqualeBuy6 Oct 202630.00 USD
BTIGRyan ZimmermanHold3 Jun 2026—
CitigroupUnnamed analystHold2 Jul 2026—
Evercore ISIVijay KumarBuy5 Oct 202624.00 USD
JefferiesMichael A SarconeHold5 Aug 202620.00 USD
Leerink PartnersMichael KratkyHold12 Oct 202620.00 USD
OppenheimerUnnamed analystHold9 Sep 2026—
Piper SandlerAdam C MaederBuy16 Oct 2026—
Piper SandlerMatt O'BrienBuy16 Oct 2026—
StephensMason CarricoBuy17 Jul 202625.00 USD
TD CowenJoshua JenningsBuy5 Aug 202628.00 USD
TruistRichard Newitter—5 Aug 202621.00 USD
UBSDanielle AntalffyHold28 Jul 202620.00 USD
UBSPatrick WoodHold28 Jul 202620.00 USD
Weiss RatingsUnnamed analyst—15 Oct 2026—
Wells FargoNathan TreybeckHold5 Aug 202619.00 USD
William BlairBrandon VazquezConflictConflicting reports · excluded5 Aug 2026—
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 06:06 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.